Biosynex SARL acquired Sensogen Deutschland GmbH.
Biosynex SARL (ENXTPA:ALBIO) completed the acquisition of Sensogen Deutschland GmbH on October 29, 2012.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.1 EUR | 0.00% | +10.87% | -38.92% |
2023 | Biosynex: merger with Theradiag completed | CF |
2023 | Biosynex SA Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-38.92% | 58.52M | |
-1.04% | 12.47B | |
-17.29% | 6.99B | |
-2.21% | 5.1B | |
+1.98% | 4.27B | |
-4.79% | 4.27B | |
-49.52% | 3.45B | |
+7.65% | 2.61B | |
-15.92% | 2.08B | |
-3.40% | 1.67B |